Clinical Trials
114 trialsExpanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma
Memorial Sloan Kettering Cancer Center
Single-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent Osteosarcoma
University of Florida
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Children's Hospital of Philadelphia
Expanded Access [11C] Methionine PET Imaging
St. Jude Children's Research Hospital
131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol
Children's Hospital of Philadelphia
BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
Aveni Foundation
Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
An Intermediate Expanded Use Trial of DFMO
Milton S. Hershey Medical Center
EMTP
Phoenix Children's Hospital
Expanded Access To Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
Jaime Leandro Foundation for Therapeutic Cancer Vaccines
Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders
OHSU Knight Cancer Institute
Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor
Rezolute
Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants
Duke University
Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors
Providence Health & Services
Fecal Microbiota Transplant for Neuroblastoma in a Single Patient
ProgenaBiome
Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas
University of California, San Francisco
EAP
Roswell Park Cancer Institute
A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies
Institute of Hematology & Blood Diseases Hospital, China
TETRAVI Expanded Access Program
Baylor College of Medicine
131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Memorial Sloan Kettering Cancer Center
131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol
University of California, San Francisco
Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)
The University of Texas Health Science Center at San Antonio
Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC
Children's Hospital of Philadelphia
Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.
Case Comprehensive Cancer Center
Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL
University of Texas Southwestern Medical Center
Expanded Access Program for GBM Subjects
Rznomics, Inc.
An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)
Lynkcell Europe
18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer
Stanford University
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma
University of Texas Southwestern Medical Center
TRIANGLE
Petrov, Andrey
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
Northwell Health
InHeVac01
University Hospital Tuebingen
InHeAb01
University Hospital Tuebingen
Expanded Access Neoantigen Vaccine in Solid Tumors
Washington University School of Medicine
Glioblastoma and Individualized Therapies
Zentrum fur Humangenetik Tuebingen
Compassionate Use of BYL 719 Alpelisib
New Mexico Cancer Research Alliance
TheraSphere
University of California, Irvine
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer
University of Texas Southwestern Medical Center
Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
Children's Hospital Medical Center, Cincinnati
Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer
University of Michigan
Firefly
Tulane University
18F-FDOPA PET in Neuroendocrine Tumours
British Columbia Cancer Agency
Therasphere for Unresectable Primary or Secondary Liver Neoplasia
H. Lee Moffitt Cancer Center and Research Institute
LEMS
Lahey Clinic
Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation
Emory University
Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer
OHSU Knight Cancer Institute
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer
Stanford University
Expanded Access [Ga-68] PSMA-11 PET Imaging
Mayo Clinic
Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch
UNC Lineberger Comprehensive Cancer Center
Compassionate Use Re-Infusion of ATLCAR.CD30
UNC Lineberger Comprehensive Cancer Center